Funds and ETFs Laboratory Corporation of America Holdings

Equities

LH

US50540R4092

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-05-03 pm EDT 5-day change 1st Jan Change
201.3 USD +0.53% Intraday chart for Laboratory Corporation of America Holdings +1.47% -11.43%

ETFs positioned on Laboratory Corporation of America Holdings

Name Weight AuM 1st Jan change Investor Rating
0.03% 1,166 M€ +0.26% -
0.03% 607 M€ +0.05% -
0.03% 389 M€ +7.11% -
0.03% 237 M€ +1.82% -
0.03% 34 M€ +6.71% -
0.03% 284 M€ -.--%
0.02% 302 M€ +4.66% -
0.02% 39 M€ +4.35% -
0.02% 1,174 M€ +23.54%
0.02% 655 M€ -.--% -
0.02% 273 M€ -.--%
0.02% 1 M€ -.--%
0.02% 18 M€ +3.28% -
0.02% 17 M€ +1.96% -
0.02% 108 M€ +2.36% -
0.01% 7 M€ +0.11% -
0.01% 34 M€ +2.67% -
0.01% 205 M€ -.--%
0.01% 6 M€ +3.89%
0.01% 8 M€ -0.02% -
0.01% 2 M€ +3.16% -
0.01% 52 M€ -0.11% -
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
201.3 USD
Average target price
239.6 USD
Spread / Average Target
+19.01%
Consensus
  1. Stock Market
  2. Equities
  3. LH Stock
  4. Funds and ETFs Laboratory Corporation of America Holdings